In addition, scientists have highlighted the anti-inflammatory and antioxidant potentials of SGLT2 inhibitors, which largely contributes to their health benefits in aging (Schönberger et al. 2023) and in neurological disorders (Tsai et al. 2021). This evidence concerns the gene SLC5A2 and nervous system disorder.